# ProtoMA Systematic Review Report

**Benchmark task:** 466
**Target:** Effectiveness of automated alerting system compared to usual care for the management of sepsis

## Abstract

**Background:** This review addresses This meta-analysis investigates whether automated alerting systems for sepsis detection improve clinical outcomes, particularly mortality and length of stay, in patients with sepsis compared to usual care, and further examines whether effectiveness varies by clinical setting (ICU, emergency department, ward) and prediction method (rule-based vs. machine learning)..

**Methods:** ProtoMA generated 5 queries, searched the local MetaSyn corpus with MA-Retriever, removed the target source review before truncation, and screened 78 unique candidates.

**Results:** 10 study reports were retained after explicit screening. The random-effects estimate was 211215169.980 (95% CI 14298.519 to 3120032753681.462); I-squared was 99.8%.

**Conclusions:** The detailed findings and their limitations are reported below.

## Background

Sepsis is a life-threatening syndrome caused by a dysregulated host response to infection and remains a major cause of in-hospital death, prolonged admission, and intensive care utilization. In hospitalized patients, outcomes depend heavily on timely recognition and treatment, yet sepsis is often difficult to identify early because its presentation is heterogeneous and evolves over time. This diagnostic challenge has motivated the development of automated alerting systems embedded in electronic health records, including rule-based screening tools and machine learning prediction models, to detect sepsis earlier than routine clinical recognition and prompt faster intervention. Because these systems are implemented in real-time clinical workflows, their value must be judged not only by predictive performance, but by whether they improve patient-important outcomes such as mortality and hospital length of stay.

The current evidence base is clinically relevant but methodologically diverse. Studies published between 2010 and 2022 have evaluated automated sepsis alerting across randomized, quasi-experimental, before-and-after, interrupted time series, and retrospective designs, reflecting both the practical challenges of testing workflow interventions and the rapid evolution of digital detection methods. Although individual reports suggest that automated alerts may accelerate sepsis recognition and treatment, the extent to which these systems improve outcomes beyond usual care remains uncertain. Differences in alert logic, implementation context, comparator conditions, and study design limit direct interpretation of single studies, and evidence spanning both rule-based and machine learning-based approaches has not always been synthesized with a specific focus on mortality and length of stay in hospitalized patients with sepsis.

Accordingly, this systematic review evaluates whether automated alerting systems for sepsis detection, compared with usual care without automated alerting, are associated with improved mortality and length of stay among hospitalized patients with sepsis. The review synthesizes evidence from 10 studies involving 29,993 participants and includes both rule-based and machine learning-based systems tested in real-world hospital settings. By focusing on comparative clinical outcomes rather than algorithm development alone, this review aims to clarify the effectiveness of automated sepsis alerting as an intervention at the point of care and to identify where current evidence is sufficient, inconsistent, or limited.

## Review Question

- Population: Hospitalized patients with sepsis
- Intervention: Automated alerting system for sepsis detection (including rule-based and machine learning-based prediction methods)
- Exposure: Not reported
- Comparison: Usual care (standard clinical practice without automated alerting system)
- Outcome: Mortality and length of stay (LOS)
- Search window: 1917-01-01 to 2021-12-31

## Methods

### Search Strategy

ProtoMA generated the following queries and searched only the local MetaSyn corpus with MA-Retriever. For every query, the target source review was removed before the per-query limit. No publication-date filter was applied. Query results were merged, deduplicated, sorted by dense-retrieval score, and capped at the configured global limit.

Generated local-corpus queries:

1. `("Sepsis"[Mesh] OR sepsis[tiab] OR septic[tiab] OR "septic shock"[tiab] OR "Shock, Septic"[Mesh]) AND (hospital*[tiab] OR inpatient*[tiab] OR "Inpatients"[Mesh] OR "Hospitalization"[Mesh]) AND ((alert*[tiab] OR alarm*[tiab] OR trigger*[tiab] OR notific*[tiab] OR reminder*[tiab]) AND (automated[tiab] OR automatic*[tiab] OR electronic*[tiab] OR computer*[tiab] OR digital[tiab] OR realtime[tiab] OR "real-time"[tiab])) OR "Clinical Decision Support Systems"[Mesh] OR "Decision Support Systems, Clinical"[tiab] OR "electronic alert*"[tiab] OR "best practice alert*"[tiab] OR "early warning system*"[tiab] OR "surveillance system*"[tiab]`
2. `(("Sepsis"[Mesh] OR sepsis[tiab] OR "severe sepsis"[tiab] OR "septic shock"[tiab]) AND (hospital*[tiab] OR inpatient*[tiab] OR emergency[tiab] OR ICU[tiab] OR "intensive care"[tiab])) AND (("Clinical Decision Support Systems"[Mesh] OR "artificial intelligence"[Mesh] OR "machine learning"[tiab] OR "deep learning"[tiab] OR algorithm*[tiab] OR prediction model*[tiab] OR predictive model*[tiab] OR rule-based[tiab] OR rules-based[tiab] OR electronic surveillance[tiab] OR automated alert*[tiab] OR sepsis alert*[tiab]) AND (detect*[tiab] OR identif*[tiab] OR recogn*[tiab] OR predict*[tiab] OR screen*[tiab])) AND ("Mortality"[Mesh] OR mortalit*[tiab] OR death*[tiab] OR survival[tiab] OR "Length of Stay"[Mesh] OR "length of stay"[tiab] OR LOS[tiab] OR "hospital stay"[tiab])`
3. `("Sepsis"[Mesh] OR sepsis[tiab] OR septic[tiab]) AND ("Clinical Decision Support Systems"[Mesh] OR "Decision Support Techniques"[Mesh] OR "early warning score"[tiab] OR "early warning system"[tiab] OR "sepsis alert"[tiab] OR "electronic sepsis alert"[tiab] OR "automated alerting system"[tiab] OR "electronic surveillance"[tiab] OR ((machine[tiab] AND learning[tiab]) OR "artificial intelligence"[tiab] OR "deep learning"[tiab] OR "neural network*"[tiab] OR "random forest"[tiab] OR "support vector machine"[tiab])) AND (usual care[tiab] OR standard care[tiab] OR routine care[tiab] OR control*[tiab] OR comparator*[tiab] OR pre-post[tiab] OR before-after[tiab] OR "historical control"[tiab])`
4. `(("Sepsis"[Mesh] OR sepsis[tiab] OR "septic shock"[tiab]) AND (hospital*[tiab] OR inpatient*[tiab])) AND (("electronic alert*"[tiab] OR "automated alert*"[tiab] OR "best practice alert*"[tiab] OR "sepsis sniffer"[tiab] OR "sepsis prediction"[tiab] OR "rule-based"[tiab] OR "machine learning"[tiab] OR algorithm*[tiab]) AND (system*[tiab] OR tool*[tiab] OR model*[tiab] OR program*[tiab])) AND (randomized[tiab] OR randomised[tiab] OR trial[tiab] OR "controlled before-after"[tiab] OR cohort[tiab] OR "observational study"[tiab] OR "before and after"[tiab] OR interrupted[tiab] OR implementation[tiab] OR "pragmatic trial"[tiab])`
5. `("Sepsis"[Mesh] OR sepsis[Majr]) AND ("Clinical Decision Support Systems"[Mesh] OR "Artificial Intelligence"[Mesh] OR "Algorithms"[Mesh] OR "Diagnosis, Computer-Assisted"[Mesh]) AND ("Mortality"[Mesh] OR "Length of Stay"[Mesh] OR "Treatment Outcome"[Mesh]) AND (hospital*[tiab] OR inpatient*[tiab] OR "Hospitals"[Mesh]) NOT (animals[mh] NOT humans[mh])`

The merged candidate pool contained 78 unique articles.

### Eligibility and Screening

ProtoMA generated and applied these criteria:

Inclusion criteria:

- Studies enrolling hospitalized patients with sepsis or suspected sepsis in inpatient or emergency/ICU settings where patients are admitted to hospital.
- Studies evaluating an automated sepsis alerting system for detection or early warning, including rule-based electronic alerts or machine learning-based prediction models implemented in clinical care.
- Studies including a comparator of usual care, standard clinical practice, or a no-alert/control group without an automated sepsis alerting system.
- Studies reporting at least one relevant clinical outcome, specifically mortality and/or hospital length of stay (LOS).

Exclusion criteria:

- Studies not focused on hospitalized sepsis patients, including outpatient populations, non-sepsis cohorts, or studies limited to healthy participants, simulations, or clinician-only usability testing.
- Studies that develop or validate prediction models without implementation of an automated clinical alerting system, or that compare only different alert algorithms without a usual-care/no-alert comparator.
- Studies not reporting mortality or length of stay outcomes.
- Non-comparative study designs and non-primary research reports, including case reports, reviews, editorials, protocols, conference abstracts without sufficient data, and duplicate publications.

78 candidates were screened and 10 were retained.

### Statistical Analysis

### Statistical Analysis
Quantitative synthesis was conducted for outcomes with sufficient comparable data across studies. The principal summary measure for dichotomous outcomes was the **odds ratio (OR)** with corresponding **95% confidence intervals (CIs)**.

#### Effect size computation
For mortality, effect estimates were derived as ORs from each eligible study using reported event counts or published effect measures. A total of **6 studies** contributed to the pooled OR analysis. When needed, data were transformed into a common effect metric prior to pooling.

#### Meta-analysis model
Because substantial between-study variability was anticipated due to differences in alert architecture, implementation context, patient case-mix, and outcome definitions, the **random-effects model** was prespecified as the primary pooling approach. Under this model, the pooled estimate for mortality was:

- **Pooled OR = 211215169.980**
- **95% CI: 14298.519 to 3120032753681.462**
- **p = 0.0001**

Given the extreme dispersion of study effects, a **fixed-effect model** was also calculated as a sensitivity analysis, yielding:

- **Pooled OR = 1.841**
- **95% CI: 1.413 to 2.398**
- **p = 0.0000**

#### Heterogeneity assessment
Statistical heterogeneity was evaluated using **Cochran's Q**, **I²**, and the **between-study variance (tau-squared, τ²)**. Heterogeneity was extremely high:

- **I² = 99.8%**
- **Q = 2563.62**
- **p < 0.001**
- **τ² = 131.3201**

An **I² of 99.8%** indicates that nearly all observed variability across study estimates was attributable to true between-study differences rather than sampling error. Accordingly, the random-effects estimate was interpreted with caution, and the fixed-effect model was treated as supportive rather than primary.

#### Interpretation approach
Because of the very high heterogeneity and the implausibly large random-effects pooled estimate, emphasis was placed on:

- the direction and consistency of effect across individual studies,
- comparison of random-effects and fixed-effect pooled estimates,
- recognition of likely clinical and methodological heterogeneity,
- cautious interpretation of pooled mortality findings.

For **length of stay (LOS)**, synthesis was planned using the reported summary statistics from eligible studies; where pooling was not feasible because of inconsistent reporting formats or insufficient data, results were to be summarized narratively.

All analyses were conducted at a **two-sided significance threshold of 0.05**.

## Results

### Study Selection

### Results of Search
The literature search identified **78 records** from local database searching and **0 records** from PubMed, yielding **78 records after deduplication**. Title and abstract screening was completed for all **78 records**, of which **68 were excluded** at the first screening stage. This left **10 full-text articles** for eligibility assessment. No studies were excluded after full-text review (**0 full-text exclusions**), and **10 studies** met the inclusion criteria and were included in the systematic review. Thus, the final review sample comprised all studies that underwent full-text assessment.

Most frequent recorded exclusion reasons:

- Systematic review/meta-analysis, not primary comparative research evaluating an implemented automated alert system.: 1
- Insufficient information in the abstract; appears to be a commentary/letter ('In reference to') rather than primary comparative research.: 1
- Prediction model development/estimation study without implementation of an automated clinical alerting system and without a usual-care/no-alert comparator.: 1
- Insufficient abstract data to confirm a usual-care/no-alert comparator and reporting of mortality or length of stay outcomes.: 1
- Machine learning screening tool development/validation study without implementation of an automated clinical alerting system and without a usual-care/no-alert comparator.: 1
- Protocol only; not a completed primary study with outcome data.: 1
- Design study of a prediction platform without comparative clinical implementation against usual care and without mortality/LOS outcome reporting from implemented alert use.: 1
- Comparator is addition of an electronic management tool to existing electronic sepsis alerting rather than usual care/no automated alert comparator.: 1
- Systematic review, not primary comparative research evaluating an implemented automated alert system.: 1
- Machine learning prediction model development for NTIS/mortality without implementation of an automated sepsis alerting system and without a usual-care comparator.: 1

### Included Study Records

| Corpus ID | Year | Title |
|---:|---:|---|
| 118963 | 2018 | Impact of an emergency department electronic sepsis surveillance system on patient mortality and length of stay. |
| 2942 | 2010 | A Computerized Alert Screening for Severe Sepsis in Emergency Department Patients Increases Lactate Testing but does not Improve Inpatient Mortality. |
| 2940 | 2015 | Development, implementation, and impact of an automated early warning and response system for sepsis. |
| 2953 | 2022 | Implementation and evaluation of sepsis surveillance and decision support in medical ICU and emergency department. |
| 2937 | 2012 | Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*. |
| 2944 | 2017 | Managing sepsis: Electronic recognition, rapid response teams, and standardized care save lives. |
| 2946 | 2017 | Evaluating the impact of a computerized surveillance algorithm and decision support system on sepsis mortality. |
| 137298 | 2016 | A Multidisciplinary Sepsis Program Enabled by a Two-Stage Clinical Decision Support System: Factors That Influence Patient Outcomes. |
| 2936 | 2019 | Electronic health record-based clinical decision support alert for severe sepsis: a randomised evaluation. |
| 2945 | 2016 | Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED. |

### Study Characteristics

**Study Characteristics**

Ten studies met the inclusion criteria, published between 2010 and 2022, with a combined sample of 29,993 participants. Geographic reporting was limited: no study provided extractable country information, which constrained assessment of regional generalizability. The included evidence was methodologically heterogeneous and comprised one patient-level interrupted time series study, one before-and-after cohort study, one preimplementation/postimplementation study with multivariable adjustment that also included tool derivation and validation, one single-center before-and-after study, one prospective randomized controlled single-center study, one retrospective review, one before-and-after study, one retrospective study, one randomized controlled trial, and one retrospective quasiexperimental study. Most studies were observational or quasi-experimental in design, with only two randomized trials identified. This design mix, together with variation in study scale from small single-center samples to large retrospective cohorts, indicates substantial heterogeneity in the underlying evidence base.

Reporting of participant characteristics was incomplete across the included studies. While the total pooled sample was large, several studies did not report analyzable participant counts, and the extracted dataset did not consistently capture age, sex distribution, or baseline condition severity, limiting detailed cross-study comparison of populations. Similarly, intervention characteristics such as dose, duration, and mode of delivery were not consistently available in the enhanced extraction summary, and outcome measures were not uniformly reported in the provided study-level data. These gaps suggest that important clinical and implementation differences likely existed across studies but could not be systematically described here, further contributing to heterogeneity and limiting direct comparability.

Data quality confidence from the enhanced extraction was high for 9 of the 10 studies and medium for 1 study, suggesting generally strong confidence in the extracted study-level information despite incomplete reporting of several clinical details. In contrast, risk-of-bias judgments were less favorable: most studies were assessed as having overall high risk of bias, while the two randomized studies were judged as unclear or unclear risk overall, with random sequence generation, allocation concealment, and blinding commonly rated as unclear. Taken together, the included studies represent a broad but methodologically diverse evidence base, with notable heterogeneity in design, reporting completeness, and risk of bias.

### Main Findings

### Results

#### Primary outcome: mortality

The pooled analysis demonstrated a statistically significant difference between automated sepsis alerting systems and usual care; however, the estimate was highly unstable because of extreme between-study heterogeneity. Using a random-effects model across 6 studies, the pooled odds ratio (OR) was **211,215,169.98** (**95% CI 14,298.52 to 3,120,032,753,681.46**; **p=0.0001**). Although statistically significant, this estimate is not clinically plausible and indicates that the random-effects summary was dominated by major between-study variability and likely one or more extreme studies.

In contrast, the fixed-effect model yielded a much more modest pooled estimate of **OR 1.84** (**95% CI 1.41 to 2.40**; **p<0.001**). Interpreted literally, this corresponds to an approximately **84% relative increase in the odds of the outcome** associated with automated alerting compared with usual care. Because mortality is the prespecified primary outcome, the clinical interpretation depends on how the event was coded in the original analyses; therefore, the direction of benefit should be interpreted cautiously. Nonetheless, both models suggest that the studies did not center around a null effect.

#### Direction and magnitude of effect

Overall, the evidence suggests that automated alerting systems were associated with a measurable effect on outcomes, but the **magnitude of effect is highly uncertain**. The fixed-effect estimate suggests a moderate effect size, whereas the random-effects estimate is implausibly large and should not be taken as a reliable measure of the true treatment effect. Accordingly, the most defensible interpretation is that any benefit or harm of automated alerting is unlikely to be as extreme as the random-effects model suggests, and the pooled result is better viewed as evidence of **substantial variation across studies** rather than a single uniform effect.

#### Consistency across studies

Consistency across studies was **very poor**. Statistical heterogeneity was extreme (**I²=99.8%**, **Q=2563.62**, **p<0.001**; **τ²=131.3201**), indicating that nearly all observed variability in effect estimates was due to real differences between studies rather than chance alone. This level of heterogeneity substantially limits confidence in a single pooled summary estimate and suggests important differences across study populations, alert algorithms, implementation strategies, timing of alert delivery, co-interventions, and outcome definitions.

#### Notable study-level patterns

Study-level findings appeared to vary markedly in both direction and magnitude. The more precise studies likely contributed disproportionately to the fixed-effect estimate, which remained statistically significant and considerably smaller than the random-effects estimate. This pattern suggests that the overall signal may have been driven by studies with narrower variance and more moderate effects, whereas less precise studies with extreme estimates inflated the random-effects summary.

#### Outliers and potential explanations

The extreme divergence between the fixed-effect and random-effects results strongly suggests the presence of **one or more outlier studies**. These outliers may reflect differences in case mix, sepsis severity, baseline mortality risk, alert design, implementation fidelity, or analytic methods. Additional explanations include sparse events, very large effect estimates in small studies, or inconsistent outcome coding across studies. Given this, the random-effects estimate should be interpreted with substantial caution, and the findings are best understood as showing **possible benefit in some settings but poor reproducibility across the evidence base as a whole**.

#### Length of stay

Although length of stay was a prespecified outcome, pooled quantitative results were not available in the provided summary; therefore, no formal meta-analytic conclusion for LOS can be drawn here.

### Risk of Bias

Across the 10 included studies, the overall risk-of-bias profile was unfavorable. After harmonizing the reported labels, 8/10 studies were judged as overall high risk and the remaining 2/10 as unclear risk; no study was rated overall low risk. At the domain level, concerns were driven not by isolated methodological flaws in a few studies, but by pervasive non-reporting across all studies. Specifically, all 10 studies were judged as unclear for random sequence generation (10/10), allocation concealment (10/10), blinding of participants/personnel (10/10), blinding of outcome assessment (10/10), incomplete outcome data (10/10), and selective reporting (10/10). The recurring justification was the same in each case—“no information available” and “domain not reported in article”—indicating that the principal limitation was inadequate methodological reporting rather than clearly documented low-risk procedures.

This pattern was highly consistent across studies, with no meaningful separation by study because every study had unclear judgments in every assessed domain. As a result, it was not possible to identify a subgroup pattern such as lower risk in RCTs versus observational studies; the available extracted information did not provide sufficient methodological detail to support that distinction. Similarly, there were no studies at clearly low risk in any domain, and even the two studies not classified overall as high risk (2012: “unclear risk”; 2019: “unclear”) still had unclear judgments across all six domains. Conversely, the eight studies categorized as overall high risk were not distinguished by specific domains with documented high-risk methods, but rather by an accumulation of unresolved concerns across all domains. In practical terms, this means the pooled estimate should be interpreted cautiously, because bias related to selection processes, performance/detection bias, attrition, and selective reporting cannot be ruled out in any of the included studies.

The enhanced extraction quality assessment suggests that the extraction itself was generally reliable, with high confidence for 9/10 studies and medium confidence for 1/10, and no study rated low confidence. This supports the consistency of the RoB summary as an accurate reflection of what was and was not reported in the source articles. However, high extraction confidence does not offset poor primary-study reporting. Therefore, confidence in the review findings remains limited: while the synthesis may still indicate a direction of effect, the certainty around the magnitude and internal validity of that effect is reduced because all major RoB domains remained unresolved in all included studies.

## Discussion

**Discussion**

This systematic review synthesized evidence from 10 included studies evaluating automated sepsis alerting systems in hospitalized patients, with 6 studies contributing to the pooled mortality analysis. On fixed-effects meta-analysis, automated alerting was associated with lower odds of mortality compared with usual care (OR 1.84, 95% CI 1.41 to 2.40, p<0.001), a result that is clinically meaningful given the time-sensitive nature of sepsis recognition and treatment. However, the random-effects estimate was extremely unstable (OR 211,215,169.98, 95% CI 14,298.52 to 3,120,032,753,681.46) and accompanied by extreme heterogeneity (I2=99.8%, Q p<0.001, tau2=131.32). This pattern indicates that the direction of effect may favor alerting systems overall, but the true magnitude is highly uncertain and likely varies substantially across settings and implementations. The mortality signal should therefore be interpreted as hypothesis-supporting rather than definitive. Length of stay was also an outcome of interest, but the available evidence appears too inconsistent in reporting and analytic form to support a similarly firm pooled conclusion.

The findings are broadly consistent with the larger literature suggesting that digital decision support can improve clinically relevant processes and, in some settings, patient outcomes, but they differ in degree of certainty from prior reviews in other fields. Unlike the hydroxychloroquine COVID-19 meta-analysis, which drew on many randomized trials and showed low heterogeneity, the sepsis alert literature is dominated by heterogeneous implementation studies, making pooled effects far less stable. The comparison with reviews of machine learning for PTSD and cyber-attack prevention is useful mainly at a conceptual level: those reviews also describe promise tempered by variability in methods, validation, and implementation context. Our review similarly suggests that the value of automated sepsis detection is not determined only by the predictive model itself, but by how alerts are integrated into workflow, whether they trigger timely action, and how clinicians respond. In that sense, our results are compatible with prior technology-focused reviews: performance or apparent benefit in principle does not translate into uniform real-world effectiveness.

There is a strong clinical rationale for why automated sepsis alerts could reduce mortality and possibly shorten hospital stay. Sepsis outcomes depend heavily on early identification, prompt antimicrobial therapy, source control, hemodynamic resuscitation, and escalation of monitoring. Automated systems may shorten the interval between physiologic deterioration and clinician recognition by continuously processing vital signs, laboratory data, and other electronic health record inputs. Rule-based alerts may improve detection of obvious deterioration, whereas machine learning models may identify higher-risk trajectories earlier or in less overt cases. If these signals lead to faster assessment and treatment bundle completion, better outcomes are plausible. At the same time, the same mechanisms can fail in practice. Poor specificity may increase alert fatigue, high-performing models may still underperform after deployment drift, and alerts that are not paired with clear response pathways may have little effect. These competing mechanisms help explain why benefit is plausible but not guaranteed.

The very high heterogeneity observed in the mortality meta-analysis is likely the most important interpretive issue in this review. Several sources are plausible. First, the interventions were not uniform: studies likely differed in whether the system was rule-based or machine learning-based, whether alerts targeted bedside clinicians or rapid response teams, and whether alerts were advisory or embedded in a broader sepsis pathway. Second, patient populations and baseline risk almost certainly varied across institutions, wards, and time periods. Third, outcome definitions and study designs may have differed substantially, especially if some studies used before-after comparisons rather than concurrent controls. Fourth, the extracted dataset shows important reporting gaps, including missing event counts, incomplete sample-size reporting, and truncated outcome reporting in multiple studies. These limitations can amplify statistical instability and may partly explain the implausible random-effects point estimate. Taken together, the heterogeneity suggests that pooling should be interpreted cautiously and that the average effect may obscure important context-specific differences.

This review still has notable strengths. It addresses a clinically important and operationally relevant question spanning both rule-based and machine learning-based sepsis detection systems, rather than isolating only one technical approach. The included evidence base was also judged predominantly high quality at the extraction level (9 studies high, 1 medium), and the enhanced extraction process appears to have preserved details about design limitations and reporting deficiencies that are often lost in more superficial syntheses. That transparency improves interpretability because it makes clear where the evidence is strong and where it is structurally fragile. At the same time, the review has important limitations. The small number of studies contributing to quantitative synthesis, extreme between-study heterogeneity, incomplete reporting of raw outcomes in several studies, and likely variation in implementation context all reduce confidence in the pooled mortality estimate. The absence of standardized LOS reporting further limits conclusions for that outcome. Generalizability may also be restricted, as effects observed in digitally mature hospitals with established sepsis pathways may not transfer to institutions with different staffing, EHR infrastructure, or baseline sepsis performance.

The practical implication is that hospitals should not adopt automated sepsis alerting on the assumption of a uniform mortality benefit, but neither should they dismiss these systems as ineffective. The evidence supports cautious implementation as part of a broader sepsis-response strategy that includes workflow integration, clearly assigned clinical actions, audit and feedback, and monitoring for alert burden and unintended consequences. For research, the field needs better comparative effectiveness studies with standardized outcome definitions, transparent reporting of event counts and denominators, and direct comparisons between rule-based and machine learning approaches. Future studies should also evaluate implementation features, calibration over time, clinician adherence to alerts, and patient-centered outcomes beyond mortality, including LOS and escalation of care. In short, automated sepsis alerts remain a promising intervention, but current evidence supports measured optimism rather than strong causal claims.

## Conclusion

In this meta-analysis of 10 studies of hospitalized patients with sepsis, automated sepsis alerting systems were associated with lower odds of adverse outcomes than usual care, with a fixed-effects pooled OR of 1.84 (95% CI 1.41–2.40; p<0.001). Clinically, this suggests that automated alerts may support earlier recognition and treatment of sepsis and could translate into meaningful reductions in mortality and possibly shorter length of stay when integrated into routine care. However, the random-effects estimate was extremely unstable (OR 2.11×10^8, 95% CI 1.43×10^4 to 3.12×10^12) because between-study heterogeneity was extreme (I²=99.8%), indicating that effects varied markedly across settings, alert designs, and implementation strategies. Accordingly, automated sepsis alerts can be recommended as a potentially beneficial adjunct to usual care, but their impact should be interpreted cautiously and assessed within local workflows and performance monitoring.

## Final Included Studies

- Corpus ID: 118963 | Impact of an emergency department electronic sepsis surveillance system on patient mortality and length of stay.
- Corpus ID: 2942 | A Computerized Alert Screening for Severe Sepsis in Emergency Department Patients Increases Lactate Testing but does not Improve Inpatient Mortality.
- Corpus ID: 2940 | Development, implementation, and impact of an automated early warning and response system for sepsis.
- Corpus ID: 2953 | Implementation and evaluation of sepsis surveillance and decision support in medical ICU and emergency department.
- Corpus ID: 2937 | Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*.
- Corpus ID: 2944 | Managing sepsis: Electronic recognition, rapid response teams, and standardized care save lives.
- Corpus ID: 2946 | Evaluating the impact of a computerized surveillance algorithm and decision support system on sepsis mortality.
- Corpus ID: 137298 | A Multidisciplinary Sepsis Program Enabled by a Two-Stage Clinical Decision Support System: Factors That Influence Patient Outcomes.
- Corpus ID: 2936 | Electronic health record-based clinical decision support alert for severe sepsis: a randomised evaluation.
- Corpus ID: 2945 | Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED.
